Truong AT, Duez C, Belayew A, Renard A, Pictet R, Bell GI, et al. Isolation and characterization of the human prolactin gene. EMBO J. 1984;3(2):429–37. https://doi.org/10.1002/j.1460-2075.1984.tb01824.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horseman ND, Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev. 1994;15(5):627–49. https://doi.org/10.1210/edrv-15-5-627.

Article  CAS  PubMed  Google Scholar 

Walker AM. S179D prolactin: antagonistic agony! Mol Cell Endocrinol. 2007;276(1–2):1–9. https://doi.org/10.1016/j.mce.2007.06.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523–631. https://doi.org/10.1152/physrev.2000.80.4.1523.

Article  CAS  PubMed  Google Scholar 

Fahie-Wilson M, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013;27(5):725–42. https://doi.org/10.1016/j.beem.2013.07.002.

Article  CAS  PubMed  Google Scholar 

Chanson P, Maiter D. The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101290. https://doi.org/10.1016/j.beem.2019.101290.

Article  PubMed  Google Scholar 

Clapp C, Aranda J, Gonzalez C, Jeziorski MC, Martinez de la Escalera G. Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol Metab. 2006;17(8):301–7. https://doi.org/10.1016/j.tem.2006.08.002.

Article  CAS  PubMed  Google Scholar 

Clapp C, Weiner RI. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology. 1992;130(3):1380–6. https://doi.org/10.1210/endo.130.3.1311239.

Article  CAS  PubMed  Google Scholar 

Macotela Y, Aguilar MB, Guzman-Morales J, Rivera JC, Zermeno C, Lopez-Barrera F, et al. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. J Cell Sci. 2006;119(Pt 9):1790–800. https://doi.org/10.1242/jcs.02887.

Article  CAS  PubMed  Google Scholar 

Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology. 1993;133(3):1292–9. https://doi.org/10.1210/endo.133.3.7689950.

Article  CAS  PubMed  Google Scholar 

Clapp C, Gonzalez C, Macotela Y, Aranda J, Rivera JC, Garcia C, et al. Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Front Horm Res. 2006;35:64–73. https://doi.org/10.1159/000094309.

Article  CAS  PubMed  Google Scholar 

Halmi NS, Parsons JA, Erlandsen SL, Duello T. Prolactin and growth hormone cells in the human hypophysis: a study with immunoenzyme histochemistry and differential staining. Cell Tissue Res. 1975;158(4):497–507. https://doi.org/10.1007/BF00220215.

Article  CAS  PubMed  Google Scholar 

Hodson DJ, Schaeffer M, Romano N, Fontanaud P, Lafont C, Birkenstock J, et al. Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nat Commun. 2012;3:605. https://doi.org/10.1038/ncomms1612.

Article  CAS  PubMed  Google Scholar 

Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol. 2010;162(3):453–75. https://doi.org/10.1530/EJE-09-0923.

Article  CAS  PubMed  Google Scholar 

Grattan DR, Kokay IC. Prolactin: a pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008;20(6):752–63. https://doi.org/10.1111/j.1365-2826.2008.01736.x.

Article  CAS  PubMed  Google Scholar 

Bernard V, Lamothe S, Beau I, Guillou A, Martin A, Le Tissier P, et al. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo. FASEB J. 2018;32(9):4791–7. https://doi.org/10.1096/fj.201701111RR.

Article  CAS  PubMed  Google Scholar 

Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest. 2002;110(7):973–81. https://doi.org/10.1172/jci15912.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron. 1997;19(1):103–13. https://doi.org/10.1016/s0896-6273(00)80351-7.

Article  CAS  PubMed  Google Scholar 

Asa SL, Kelly MA, Grandy DK, Low MJ. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology. 1999;140(11):5348–55. https://doi.org/10.1210/endo.140.11.7118.

Article  CAS  PubMed  Google Scholar 

Bernard V, Villa C, Auguste A, Lamothe S, Guillou A, Martin A, et al. Natural and molecular history of prolactinoma: insights from a Prlr(-/-) mouse model. Oncotarget. 2018;9(5):6144–55. https://doi.org/10.18632/oncotarget.23713.

Article  PubMed  Google Scholar 

Sobrinho LG. Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary. 2003;6(1):35–9. https://doi.org/10.1023/a:1026229810876.

Article  PubMed  Google Scholar 

Miao X, Fu Z, Luo X, Wang J, Yuan L, Zhao S, et al. A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma. Front Endocrinol (Lausanne). 2024;15:1369729. https://doi.org/10.3389/fendo.2024.1369729.

Article  PubMed  Google Scholar 

Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023;19(12):722–40. https://doi.org/10.1038/s41574-023-00886-5.

Article  PubMed  Google Scholar 

Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996;17(6):639–69. https://doi.org/10.1210/edrv-17-6-639.

Article  CAS  PubMed  Google Scholar 

Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007;9(4):464–76. https://doi.org/10.1111/j.1463-1326.2006.00671.x.

Article  CAS  PubMed  Google Scholar 

Marano RJ, Tickner J, Redmond SL. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. PLoS ONE. 2013;8(5):e63952. https://doi.org/10.1371/journal.pone.0063952.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab. 2010;21(9):569–77. https://doi.org/10.1016/j.tem.2010.06.001.

Article  CAS  PubMed  Google Scholar 

Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology. 1991;128(6):2776–84. https://doi.org/10.1210/endo-128-6-2776.

Article  CAS